Democrats on the U.S. Senate's health committee launched an investigation on Tuesday into Health Secretary Robert F. Kennedy ...

The NDP may be on the verge of blowing up B.C.’s process for drug approvals after 10 experts resigned from the province’s ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

Following reports of NDMA impurity, CDSCO has directed state drug controllers to monitor NDMA levels in Ranitidine, a common ...

Several high-ranking members of the National Multi-Sectorial Steering Committee tasked with combating illicit drugs in ...

The U.S. Department of Justice (DOJ) is accepting public comments on a proposed rule that would provide guidance around the government’s restoration of Second Amendment gun rights for people who’ve ...

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...

Sarepta decision to halt Duchenne treatment continues to frustrate families; FDA reinstate a quarter of DOGE cuts; Contract research organizations report higher than expected pharma and biotech Q2 ...

The Wood County Democratic Executive Committee will meet at 6:30 p.m. Thursday, Aug. 7, at the Parkersburg Marietta Building ...

Three years into disbursements, strategies vary — and so does transparency. Some governments submitted required reports only ...